Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China.
Adv Mater. 2019 Jan;31(3):e1802725. doi: 10.1002/adma.201802725. Epub 2018 Sep 10.
Recently, diverse functional materials that take subcellular structures as therapeutic targets are playing increasingly important roles in cancer therapy. Here, particular emphasis is placed on four kinds of therapies, including chemotherapy, gene therapy, photodynamic therapy (PDT), and hyperthermal therapy, which are the most widely used approaches for killing cancer cells by the specific destruction of subcellular organelles. Moreover, some non-drug-loaded nanoformulations (i.e., metal nanoparticles and molecular self-assemblies) with a fatal effect on cells by influencing the subcellular functions without the use of any drug molecules are also included. According to the basic principles and unique performances of each treatment, appropriate strategies are developed to meet task-specific applications by integrating specific materials, ligands, as well as methods. In addition, the combination of two or more therapies based on multifunctional nanostructures, which either directly target specific subcellular organelles or release organelle-targeted therapeutics, is also introduced with the intent of superadditive therapeutic effects. Finally, the related challenges of critical re-evaluation of this emerging field are presented.
近年来,以亚细胞结构为治疗靶点的各种功能材料在癌症治疗中发挥着越来越重要的作用。这里特别强调了四种疗法,包括化疗、基因治疗、光动力疗法(PDT)和高热疗法,这些方法通过特异性破坏亚细胞器来最广泛地用于杀死癌细胞。此外,还包括一些非载药的纳米制剂(即金属纳米粒子和分子自组装体),它们通过影响细胞的亚细胞功能而无需使用任何药物分子,对细胞具有致命影响。根据每种治疗方法的基本原则和独特性能,通过整合特定的材料、配体和方法,开发出合适的策略来满足特定任务的应用。此外,还介绍了基于多功能纳米结构的两种或多种疗法的联合,这些疗法要么直接针对特定的亚细胞器,要么释放针对细胞器的治疗药物,以期达到增效治疗效果。最后,提出了对这一新兴领域进行批判性再评估的相关挑战。
Expert Opin Drug Deliv. 2022-6
Eur J Pharm Biopharm. 2015-6
Adv Drug Deliv Rev. 2024-6
ACS Appl Mater Interfaces. 2018-2-26
Int J Nanomedicine. 2025-8-5
Mol Cancer. 2025-6-9
Int J Nanomedicine. 2025-5-29
Med Rev (2021). 2024-9-12
Pharmaceutics. 2025-2-5